Oracle's Backlog: Potential Windfall or Time Bomb?
Backlogs can unlock revenue visibility, but they can also mask quality issues. This article explains how to assess or...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesBacklogs can unlock revenue visibility, but they can also mask quality issues. This article explains how to assess or...
NVIDIA leads AI chips while MICRON powers AI memory. This in-depth comparison helps investors decide the better buy: ...
As AI demand reshapes chips, Intel and Arm sit at opposite ends of the risk spectrum. This analysis weighs which AI-e...
A key downgrade and a rival upgrade have split the investor view on CrowdStrike, shifting focus to the Mythos cycle a...
The (nrxp) 2026 earnings call highlights a shifting biotech landscape. This article breaks down what the results mean...
MoneyHero fans will be watching the 2025 earnings with a keen eye for growth, margins, and the companys path to profi...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
SMCI stock has been volatile in 2026 as AI infrastructure demand collides with a large financing plan. This piece wei...
Thinking about SpaceX stock while it trades under $200? This guide lays out how to evaluate the opportunity, potentia...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
Rambus rides AI infrastructure tailwinds but keeps a neutral stance as investors weigh valuation against accelerating...
Markets feel expensive, but Warren Buffett keeps it simple. This article explores the one low-cost investment he’s tr...